Neuropace, Inc. NPCE Deferred Tax Assets, Valuation Allowance
Deferred Tax Assets, Valuation Allowance at other companies
Other financials
Where this comes from
Reported directly by Neuropace, Inc. in its filing.
Tagged under the XBRL concept us-gaap:DeferredTaxAssetsValuationAllowance.
The official record: Neuropace, Inc.’s 10-K, filed March 3, 2026, on SEC EDGAR. View the filing →
Ask your AI about Neuropace, Inc.'s deferred tax assets, valuation allowance.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Neuropace, Inc.'s deferred tax assets, valuation allowance?
- Neuropace, Inc. (NPCE) reported deferred tax assets, valuation allowance of $85.71M in Q4 2025.
- How has Neuropace, Inc.'s deferred tax assets, valuation allowance changed year-over-year?
- Neuropace, Inc.'s deferred tax assets, valuation allowance increased by 9.6% year-over-year, from $78.19M to $85.71M.
- What is the long-term trend for Neuropace, Inc.'s deferred tax assets, valuation allowance?
- Over 5 years (2020 to 2025), Neuropace, Inc.'s deferred tax assets, valuation allowance has grown at a 14.2% compound annual growth rate (CAGR), from $44.22M to $85.71M.